Evox Therapeutics

Some diseases remain untreatable because medicines can’t reach the right cells or cross critical biological barriers.

Evox is using engineered exosomes – the body’s natural delivery vehicles – to transport therapies to previously inaccessible tissues, including the brain and central nervous system. Their ExoEdit™ platform is unlocking targeted treatments for rare and life-threatening conditions such as Spinocerebellar Ataxia type 2 (SCA2), Amyotrophic Lateral Sclerosis (ALS) and Huntington’s disease, with the potential to transform care where conventional drugs fall short.